Table 4.
Conventional cytogenetic analysis |
FISH analysis* |
|||
---|---|---|---|---|
Patient no. | Age (years) | Karyotype | Abnormal nuclei (%) | Interphase signal pattern |
66† | 7 W | 47,XY,+8,t (11;19) (q23;p13.1) [20] | 82.6 | 1R1G2F |
67 | 5 M | 46,XY,t (2;19;11) (p11.2;p13.1;q23) [2] | 2.8 | 2R2G1F |
68 | 13 | 46,XX,t (2;12) (p11.2;q13),add(7) (p15),t (11;19) (q23;p13.1),add(17) (q25) [20] | 91.2 | 1R1G2F |
69† | 20 | 46,XX,t (11;19) (q23;p13.1) [18]/46,XX[12] | 71.4 | 1R1G2F |
70 | 30 | 46,XX,t (11;19) (q23;p13.1) [7]/46,idem,add(13) (p12) [13] | 56.4 | 1R1G2F |
71† | 34 | 47,XX,+8,t (11;19) (q23;p13.1),del(13) (q12q14) [20] | 88.8 | 1R1G2F |
72 | 44 | 46,XY,t (11;19) (q23;p13.1),−14,t (15;21) (q22;q22) [1]/46,XY[29] | 12.8 | 1R1G2F |
73 | 49 | 46,XX,t (11;19) (q23;p13.1) [19]/46,XX[1] | 81.8 | 1R1G2F |
74 | 51 | 46,XX,t (11;19) (q23;p13.1) [20] | 96.8 | 1R1G2F |
75 | 52 | 46,XX,t (11;19) (q23;p13.1) [21] | 81.6 | 1R1G2F |
76 | 55 | 46,XX,t (11;19) (q23;p13.1) [20] | 80.6 | 1R1G2F |
77† | 55 | 46,XX,t (11;19) (q23;p13.1) [12]/46,XX[10] | 50.4 | 1R1G2F |
78† | 58 | 45-48,XY,t (11;19) (q23;p13.1),+i(13) (q10) [cp25]/46,XY,i(17) (q10) [2]/ 46,XY[13] | 96.8 | 1R1G2F |
79 | 58 | 46,XX,t (11;19) (q23;p13.1) [20] | 85 | 1R1G2F |
80 | 60 | 46,XX,del(7) (q22),t (11;19) (q23;p13.1) [16]/46,XY[4] | 47.6 | 1R1G2F |
81 | 60 | 46,XY,t (11;19) (q23;p13.1) [20] | 85.4 | 1R1G2F |
82 | 68 | 46,XX,t (11;19) (q23;p13.1) [30] | 94.8 | 1R1G2F |
83 | 78 | 46,XX,t (11;19) (q23;p13.1) [20] | 96.8 | 1R1G2F |
F, fusion (yellow); G, green; M, months; R, red; W, weeks.
A total of 500 interphase nuclei were analyzed by two technologists (250 nuclei each).
The breakpoint for these patients was initially evaluated as 19p13.3.